INTENSITY THERAPEUTICS INC (INTS) Stock News

NASDAQ:INTS - US45828J1034 - Common Stock

0.291 USD

-0.01 (-3.61%)

Last: 8/28/2025, 8:18:45 PM

0.2741 USD

-0.02 (-5.81%)

Pre-Market: 8/29/2025, 6:01:09 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

INTS Latest News, Press Relases and Analysis

All

Press Releases

9 days ago - By: Chartmill - Mentions: ARCO COTY WINT INSG ...

News Image

Stay updated with the stocks that are on the move in today's after-hours session.

17 days ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

22 days ago - By: The Motley Fool

Intensity (INTS) Q2 Net Loss Drops 50%

22 days ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

25 days ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025

2 months ago - By: Benzinga - Mentions: IGC AEMD MREO RARE ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

3 months ago - By: Benzinga - Mentions: SLP HCTI HSDT RSLS ...

12 Health Care Stocks Moving In Thursday's Intraday Session

3 months ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics, Inc. Announces Pricing of Public Offering

3 months ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

3 months ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics, Inc. Announces Patients Receiving INT230-6 Prior to the Start of Standard-of-Care May Achieve High Levels of Tumor Necrosis in the Ongoing Randomized Controlled Phase 2 INVINCIBLE-4 Study

3 months ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

3 months ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment Options on the Horizon

4 months ago - By: Intensity Therapeutics Inc.

Intensity Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update